Introduction {#h0.0}
============

Male circumcision (MC) reduces the risk of HIV acquisition in men by 50 to 60% ([@B1]--[@B3]) and decreases the incidence and prevalence of herpes simplex virus 2 (HSV-2) ([@B4]) and human papillomavirus (HPV) ([@B4], [@B5]). The impact of MC on classical bacterial sexually transmitted infections (STIs), such as *Chlamydia trachomatis*, *Neisseria gonorrhoeae*, *Treponema pallidum*, and *Trichomonas vaginalis* infection, is more equivocal ([@B4], [@B6]--[@B8]). Women with circumcised male partners are at lower risk for STIs ranging from HPV to *Trichomonas vaginalis* infection ([@B6], [@B9]). This suggests that MC reduces the risk of viral STIs in men and of STI transmission to their female partners ([@B10]).

MC is hypothesized to reduce HIV risk in men by changing the penile anatomy and by altering the genital microbiology ([@B11]). With respect to the anatomic changes, MC removes the prepuce, which decreases the number of available HIV target cells on the penis ([@B11], [@B12]). It remains unclear whether decreases in viral STIs post-MC contribute to HIV risk reduction. HSV-2 infection increases the risk of HIV in observational studies ([@B13], [@B14]), but trials aimed at controlling viral and classical bacterial STIs have largely failed to reduce HIV transmission ([@B15], [@B16]). Removal of the preputial tissue also eliminates the moist subpreputial environment, which can modify the genital bacterial communities (i.e., the microbiota) and may have a broad impact on the genital microbiology ([@B17]).

Recently, genital epithelial inflammation associated with bacterial antigens has emerged as a possible factor in increasing susceptibility of genital HIV target cells ([@B18]--[@B23]). These findings suggest that specific groups of genital bacteria, including those not associated with classical STIs, could elicit local immune responses that promote epithelial inflammation and recruitment of HIV target cells. Thus, changes in the genital bacterial microbiota could be linked to HIV acquisition.

Previously, we reported the impact of MC on the coronal sulcus microbiota composition in 12 men ([@B17]). However, this study lacked uncircumcised controls. In the current study, we assessed the effect of MC on the genital microbiota using absolute abundance. In addition, we applied novel analyses to assess the microbiota changes attributable to MC. We hypothesized that MC would significantly decrease coronal sulcus bacterial abundance and modify the microbiota in participants randomly assigned to receive MC but not in those who remained uncircumcised. Here, we report a study of penile coronal sulcus microbiota in 77 control and 79 intervention-arm participants from the Rakai MC randomized controlled trial in Uganda.

RESULTS {#h1}
=======

Study participant profile at enrollment. {#h1.1}
----------------------------------------

At enrollment, men from the control and intervention arms had similar sociodemographic characteristics, sexual practices, sexually transmitted infections, and symptoms ([Table 1](#tab1){ref-type="table"}).

###### 

Demographic characteristics, sexual behaviors, and symptoms of sexually transmitted infections for the control and intervention arms at enrollment

  Characteristic                                             No. (%) in group   
  ---------------------------------------------------------- ------------------ -----------
  Age (yr)                                                                      
   15--19                                                    1 (1.3)            1 (1.3)
   20--24                                                    13 (16.9)          15 (19.0)
   25--29                                                    21 (27.3)          25 (31.6)
   30--49                                                    42 (54.5)          38 (48.1)
  Marital status                                                                
   Currently married, monogamous                             70 (91.0)          71 (89.9)
   Currently married, polygamous                             7 (9.0)            8 (10.1)
  No. of sexual partners in past yr                                             
   1                                                         45 (58.4)          45 (57.0)
   2                                                         23 (29.9)          26 (32.9)
   ≥3                                                        9 (11.7)           8 (10.1)
  Nonmarital sexual relationships                                               
   No                                                        66 (85.7)          67 (84.8)
   Yes                                                       11 (14.3)          12 (15.2)
  Condom use in past yr                                                         
   None                                                      46 (59.7)          54 (68.3)
   Inconsistent use                                          30 (39.0)          24 (30.4)
   Consistent use                                            1 (1.3)            1 (1.3)
  Syphilis infection                                                            
   No                                                        72 (93.5)          73 (92.4)
   Yes                                                       4 (5.2)            5 (6.3)
   Not tested                                                1 (1.3)            1 (1.3)
  HSV-2 infection                                                               
   No                                                        36 (46.8)          37 (46.8)
   Yes                                                       32 (41.5)          32 (40.5)
   Indeterminate                                             9 (11.5)           9 (11.4)
   Not tested                                                1 (1.3)            1 (1.3)
  Self-reported symptoms of sexually transmitted infection                      
   Genital ulcer disease                                     0 (0.0)            0 (0.0)
   Urethral discharge                                        0 (0.0)            1 (1.3)
   Dysuria                                                   0 (0.0)            0 (0.0)

Coronal sulcus bacteria in the uncircumcised penis at enrollment. (i) Prevalence. {#h1.2}
---------------------------------------------------------------------------------

At enrollment, the prevalences of coronal sulcus bacterial were comparable between the two study arms ([Table 2](#tab2){ref-type="table"}). Some of the most common coronal sulcus bacteria seen at enrollment included those from the *Prevotellaceae*, *Veillonellaceae*, *Clostridiales* family XI, *Actinomycetaceae*, *Coriobacteriaceae*, and *Porphyromonadaceae*. Two groups of bacteria from the order *Clostridiales* were highly prevalent but could not be assigned with sufficient confidence to known lower taxa and are referred to as unclassified *Clostridiales* family XI and unclassified *Clostridiales* ([Table 2](#tab2){ref-type="table"}).

###### 

Prevalences and proportional abundances of the 40 most common coronal sulcus bacteria in the control and intervention arms at enrollment^[*a*](#ngtab2.1)^

  Family                       Genus                                    Prevalence (%) in group   Avg proportional abundance \[% (SD)\] in group                 
  ---------------------------- ---------------------------------------- ------------------------- ------------------------------------------------ ------------- -------------
  *Clostridiales* family XIa   *Peptoniphilus* spp.                     74 (96.1)                 72 (91.1)                                        5.4 (5.9)     5.1 (5.8)
  *Clostridiales* family XIa   *Anaerococcus* spp.                      71 (92.2)                 68 (86.1)                                        5.1 (8.1)     4.3 (6.2)
  NA                           Unclassified *Clostridiales*             69 (89.6)                 70 (88.6)                                        15.9 (16.0)   14.3 (14.5)
  *Prevotellaceae*             *Prevotella* spp.                        69 (89.6)                 67 (84.8)                                        21.4 (17.0)   23.1 (20.5)
  *Clostridiales* family XIa   *Finegoldia* spp.                        63 (81.8)                 64 (81.0)                                        6.5 (8.3)     7.1 (10.6)
  *Clostridiales* family XIa   *Murdochiella* spp.                      62 (80.5)                 58 (73.4)                                        3.2 (4.7)     5.2 (8.6)
  *Porphyromonadaceae*         *Porphyromonas* spp.                     61 (79.2)                 55 (69.6)                                        5.4 (6.1)     4.8 (8.4)
  *Corynebacteriaceae*         *Corynebacterium* spp.                   57 (74.0)                 52 (65.8)                                        12.2 (21.2)   8.5 (18.8)
  *Clostridiales* family XI    Unclassified *Clostridiales* Family XI   54 (70.1)                 53 (67.1)                                        0.7 (0.8)     0.8 (1.5)
  *Veillonellaceae*            *Dialister* spp.                         53 (68.8)                 43 (54.4)                                        1.6 (1.9)     1.0 (1.6)
  *Veillonellaceae*            *Negativicoccus* spp.                    40 (51.9)                 36 (45.6)                                        1.0 (2.4)     0.8 (1.8)
  *Peptostreptococcaceae*      *Peptostreptococcus* spp.                31 (40.3)                 36 (45.6)                                        0.9 (2.1)     1.3 (2.7)
  *Actinomycetaceae*           *Mobiluncus* spp.                        38 (49.4)                 26 (32.9)                                        1.5 (5.2)     1.1 (3.8)
  *Bifidobacteriaceae*         *Gardnerella* spp.                       33 (42.9)                 25 (31.6)                                        1.8 (5.9)     0.9 (3.2)
  *Lactobacillaceae*           *Lactobacillus* spp.                     26 (33.8)                 28 (35.4)                                        2.4 (10.7)    8 (21.0)
  *Staphylococcaceae*          *Staphylococcus* spp.                    29 (37.7)                 21 (26.6)                                        1.4 (3.9)     1.1 (6.0)
  *Ruminococcaceae*            *Saccharofermentans* spp.                28 (36.4)                 21 (26.6)                                        0.3 (0.6)     0.5 (1.9)
  *Streptococcaceae*           *Streptococcus* spp.                     26 (33.8)                 19 (24.1)                                        1.3 (6.1)     0.5 (2.8)
  *Actinomycetaceae*           *Actinomyces* spp.                       26 (33.8)                 17 (21.5)                                        0.1 (0.5)     0.1 (0.2)
  *Veillonellaceae*            *Veillonella* spp.                       26 (33.8)                 14 (17.7)                                        0.5 (1.5)     0.6 (3.1)
  *Peptococcaceae* 1           *Peptococcus* spp.                       25 (32.5)                 14 (17.7)                                        0.1 (0.1)     0.04 (0.1)
  *Coriobacteriaceae*          *Olsenella* spp.                         20 (26.0)                 19 (24.1)                                        0.1 (0.2)     0.1 (0.2)
  *Actinomycetaceae*           *Arcanobacterium* spp.                   23 (29.9)                 14 (17.7)                                        0.1 (0.2)     0.1 (0.2)
  *Lachnospiraceae*            *Howardella* spp.                        19 (24.7)                 9 (11.4)                                         0.1 (0.1)     0.03 (0.1)
  *Clostridiales* family XIa   *Parvimonas* spp.                        17 (22.1)                 10 (12.7)                                        0.2 (0.5)     0.3 (1.2)
  *Coriobacteriaceae*          *Atopobium* spp.                         14 (18.2)                 12 (15.2)                                        0.1 (0.2)     0.2 (1.1)
  *Leptotrichiaceae*           *Sneathia* spp.                          13 (16.9)                 13 (16.5)                                        0.2 (0.8)     0.3 (1.4)
  *Sutterellaceae*             *Sutterella* spp.                        13 (16.9)                 12 (15.2)                                        0.1 (0.2)     0.03 (0.1)
  *Lachnospiraceae*            *Moryella* spp.                          14 (18.2)                 7 (8.9)                                          0.1 (0.2)     0.03 (0.1)
  *Peptostreptococcaceae*      *Peptostreptococcaceae family*           12 (15.6)                 9 (11.4)                                         0.1 (0.5)     0.03 (0.1)
  *Spirochaetaceae*            *Treponema* spp.                         10 (13.0)                 11 (13.9)                                        0.2 (0.6)     0.2 (0.5)
  *Fusobacteriaceae*           *Fusobacterium* spp.                     8 (10.4)                  13 (16.5)                                        0.2 (0.8)     0.8 (3.8)
  *Synergistaceae*             *Pyramidobacter* spp.                    13 (16.9)                 7 (8.9)                                          0.2 (0.8)     0.2 (0.8)
  *Aerococcaceae*              *Facklamia* spp.                         12 (15.6)                 8 (10.1)                                         0.1 (0.3)     0.1 (0.5)
  *Clostridiales* family XIa   *Anaerosphaera* spp.                     9 (11.7)                  11 (13.9)                                        0.02 (0.1)    0.1 (0.2)
  *Micrococcaceae*             *Kocuria* spp.                           10 (13.0)                 8 (10.1)                                         0.05 (0.2)    0.1 (0.2)
  *Veillonellaceae*            *Megasphaera* spp.                       10 (13.0)                 8 (10.1)                                         0.2 (0.6)     0.1 (0.4)
  *Micrococcaceae*             *Micrococcus* spp.                       8 (10.4)                  10 (12.7)                                        0.04 (0.2)    0.04 (0.1)
  *Bacillales* family XI       *Gemella* spp.                           10 (13.0)                 6 (7.6)                                          0.04 (0.1)    0.03 (0.1)
  *Burkholderiaceae*           *Ralstonia* spp.                         13 (16.9)                 2 (2.5)                                          0.1 (0.3)     0.01 (0.1)

\*, false discovery rate (FDR)-adjusted *P* value \< 0.05.

(ii) Relative abundance. {#h1.3}
------------------------

Most coronal sulcus bacteria were observed in relatively low abundances ([Table 2](#tab2){ref-type="table"}). *Prevotella* spp. were the most dominant, followed by unclassified members of the *Clostridiales* and *Corynebacterium* spp. Six others---*Peptoniphilus* spp., *Anaerococcus* spp., *Finegoldia* spp., *Murdochiella* spp., *Porphyromonas* spp., and *Lactobacillus* spp.---were found at relative abundances of approximately 5%. The remaining coronal sulcus bacteria were detected at lower than 1% ([Table 1](#tab1){ref-type="table"}).

Male circumcision reduces coronal sulcus bacterial load. {#h1.4}
--------------------------------------------------------

At enrollment, similar mean bacterial loads were seen in the two study groups based on measurements of the bacterial 16S rRNA gene, with an average of 1.4 × 10^5^ copies (standard deviation \[SD\] = 3.1 × 10^5^) in the control arm and 2.0 × 10^5^ copies (SD = 4.8 × 10^5^) in the intervention arm. At year 1, the total bacterial load decreased significantly in both arms. In the uncircumcised men, the average bacterial load decreased to 5.7 × 10^4^ copies (SD = 1.19 × 10^5^), but the circumcised men had an average of 3.8 × 10^4^ copies (SD = 1.80 × 10^5^) (log response ratio *P* = 0.048) ([Fig. 1](#fig1){ref-type="fig"}). Thus, MC significantly decreased the coronal sulcus bacterial load relative to changes in uncircumcised men.

![Changes in the coronal sulcus bacterial load as measured by the log response ratio for the uncircumcised (Contr.; in red) versus the circumcised (Interv.; in orange) men, shown by group (top panel) and by individual (bottom panel). In the group comparison, the box of each box plot denotes the interquartile range (IQR) (quartile 1 \[Q1\] to Q3) and the corresponding median, whereas the whiskers signify the upper and lower 1.5× IQR. Outliers are shown as open symbols in each box plot. There was a statistically significant reduction in bacterial load for the circumcised men compared to that for the uncircumcised men (*P* = 0.048). As shown in the scatter plot in the bottom panel, although a decrease was observed for many individuals from both groups, more circumcised men showed decreases (i.e., negative log response ratios) (62/79, 78.5%) than did those that remained uncircumcised (51/77, 66.2%).](mbo0021314930001){#fig1}

Male circumcision significantly altered prevalences of coronal sulcus bacteria. {#h1.5}
-------------------------------------------------------------------------------

Fifteen coronal sulcus bacteria significantly decreased in prevalence post-MC (*P* \< 0.05), among which 12 were strict anaerobes, including *Porphyromonas* spp. (ΔΔPrevalence = −43.10%), *Prevotella* spp. (ΔΔPrevalence = −34.21%), *Negativicoccus* spp. (ΔΔPrevalence = −28.95%), *Dialister* spp. (ΔΔPrevalence = −30.18%), *Mobiluncus* spp. (ΔΔPrevalence = −13.69%), and six genera from *Clostridiales* family XI, among others ([Table 3](#tab3){ref-type="table"}). The reductions in anaerobe prevalence due to MC were often substantial, but MC did not significantly reduce all anaerobes; notably, *Atopobium* spp., *Sneathia* spp., and *Megasphaera* spp. showed no statistically significant decrease post-MC.

###### 

Prevalences and changes in prevalence of the 40 most common coronal sulcus bacteria for uncircumcised and circumcised men at year 1

  Bacterial group                          Oxygen tolerance^[*a*](#ngtab3.1)^   Prevalence (%)[*^b^*](#ngtab3.2)   ΔΔPrevalence (%)[*^c^*](#ngtab3.3)   
  ---------------------------------------- ------------------------------------ ---------------------------------- ------------------------------------ --------
  *Peptoniphilus* spp.                     AN                                   71 (92.2)                          37 (46.8)\*\*                        −40.41
  *Anaerococcus* spp.                      AN                                   71 (92.2)                          59 (74.7)                            −11.39
  Unclassified *Clostridiales* spp.        NA                                   65 (84.4)                          38 (48.1)\*\*                        −35.31
  *Prevotella* spp.                        AN                                   70 (90.9)                          41 (51.9)\*\*                        −34.21
  *Finegoldia* spp.                        AN                                   61 (79.2)                          38 (48.1)\*\*                        −30.31
  *Murdochiella* spp.                      AN                                   51 (66.2)                          12 (15.2)\*\*                        −43.94
  *Porphyromonas* spp.                     AN                                   62 (80.5)                          23 (29.1)\*\*                        −43.10
  *Corynebacterium* spp.                   FAN                                  71 (92.2)                          77 (97.5)\*\*                        13.46
  Unclassified *Clostridiales* family XI   NA                                   55 (71.4)                          20 (25.3)\*\*                        −43.07
  *Dialister* spp.                         AN                                   47 (61.0)                          13 (16.5)\*\*                        −30.18
  *Negativicoccus* spp.                    AN                                   35 (45.5)                          8 (10.1)\*\*                         −28.95
  *Peptostreptococcus* spp.                AN                                   32 (41.6)                          13 (16.5)\*                          −30.41
  *Mobiluncus* spp.                        AN                                   31 (40.3)                          8 (10.1)\*                           −13.69
  *Gardnerella* spp.                       FAN                                  34 (44.2)                          32 (40.5)                            7.56
  *Lactobacillus* spp.                     FAN/AN/MAE                           32 (41.6)                          35 (44.3)                            1.07
  *Staphylococcus* spp.                    FAN                                  48 (62.3)\*                        69 (87.3)\*\*                        36.08
  *Saccharofermentans* spp.                AN                                   21 (27.3)                          10 (12.7)                            −4.83
  *Streptococcus* spp.                     FAN                                  34 (44.2)                          28 (35.4)                            1.00
  *Actinomyces* spp.                       FAN                                  27 (35.1)                          8 (10.1)                             −12.69
  *Veillonella* spp.                       AN                                   26 (33.8)                          16 (20.3)                            2.53
  *Peptococcus* spp.                       AN                                   14 (18.2)                          7 (8.9)                              5.42
  *Olsenella* spp.                         AN                                   19 (24.7)                          5 (6.3)                              −16.42
  *Arcanobacterium* spp.                   FAN                                  15 (19.5)                          4 (5.1)                              −2.27
  *Howardella* spp.                        AN                                   18 (23.4)                          5 (6.3)                              −3.76
  *Parvimonas* spp.                        AN                                   13 (16.9)                          12 (15.2)                            7.73
  *Atopobium* spp.                         AN                                   18 (23.4)                          11 (13.9)                            −6.46
  *Sneathia* spp.                          AN                                   15 (19.5)                          9 (11.4)                             −7.66
  *Sutterella* spp.                        AN                                   15 (19.5)                          2 (2.5)\*                            15.26
  *Moryella* spp.                          AN                                   11 (14.3)                          4 (5.1)                              0.10
  *Peptostreptococcaceae* family           NA                                   4 (5.2)                            1 (1.3)                              0.26
  *Treponema* spp.                         AN                                   8 (10.4)                           4 (5.1)                              −6.26
  *Fusobacterium* spp.                     AN                                   17 (22.1)                          11 (13.9)                            −14.22
  *Pyramidobacter* spp.                    AN                                   7 (9.1)                            3 (3.8)                              2.73
  *Facklamia* spp.                         FAN                                  17 (22.1)                          21 (26.6)                            9.96
  *Anaerosphaera* spp.                     AN                                   9 (11.7)                           7 (8.9)                              −5.06
  *Kocuria* spp.                           AE                                   20 (26.0)                          36 (45.6)\*\*                        22.46
  *Megasphaera* spp.                       AN                                   11 (14.3)                          10 (12.7)                            1.23
  *Micrococcus* spp.                       AE                                   22 (28.6)                          39.24                                8.40
  *Gemella* spp.                           FAN                                  15 (19.5)                          13 (16.5)                            2.37
  *Ralstonia* spp.                         AE                                   16 (20.8)                          2 (2.5)                              −3.90

 AN, strictly anaerobic; AE strictly aerobic; FAN, facultative anaerobic; MAE, microaerophilic; NA, no data.

 \*\*, FDR-adjusted *P* value \< 0.0001 for change in prevalence over time (i.e., ΔPrevalence); \*, FDR-adjusted *P* value \< 0.05 for ΔPrevalence.

 ΔΔPrevalence, shown as a percentile, is the change in prevalence seen for the circumcised men over time compared to that for men that remain uncircumcised.

Seven coronal sulcus bacteria became more prevalent post-MC. Among these, five also increased in prevalence in the uncircumcised men over time, suggesting either an effect of time or changes in behavior with participation in the trial. Nevertheless, a greater number of the circumcised than of the uncircumcised men acquired these specific bacteria, as shown by the positive ΔΔPrevalence values ([Table 3](#tab3){ref-type="table"}). The aerobic *Kocuria* spp. and the facultative anaerobic *Facklamia* spp. were the two types of bacteria that became more prevalent exclusively in the circumcised men. Other bacteria were uncommon in the uncircumcised penis but increased in prevalence post-MC (see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material).

Male circumcision modified coronal sulcus microbiota biodiversity and composition. (i) Microbiota biodiversity. {#h1.6}
---------------------------------------------------------------------------------------------------------------

MC significantly reduced the evenness of the microbiota, indicating a general decrease in the number of dominant coronal sulcus bacteria post-MC (*E* treatment effect = −0.053; 95% CI = −0.101 to −0.005). In addition, MC also significantly decreased the structural diversity of the microbiota (*D* treatment effect = −1.26; 95% CI = −2.04 to −0.52)

(ii) Microbiota composition. {#h1.7}
----------------------------

MC reshaped the composition of the coronal sulcus microbiota, producing a more homogeneous post-MC profile ([Fig. 2A and B](#fig2){ref-type="fig"}). While both study groups show significant temporal changes in microbiota composition, the change was more marked in the circumcised men (PerMANOVA *F* statistic = 13.1; *P* \< 0.001) ([Fig. 2A](#fig2){ref-type="fig"}; see also [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material) than in the uncircumcised men (PerMANOVA *F* statistic = 3.1l *P* = 0.02) ([Fig. 2B](#fig2){ref-type="fig"}; see also [Fig. S1](#figS1){ref-type="supplementary-material"}).

![The nonmetric multidimensional scaling (nMDS) ordination plots enable the visualization of individuals' microbiota over time. In nMDS plots, each data point represents an individual's microbiota at one time point. The centroids and 95% confidence ellipses for each study group are as shown. Here, the coronal sulcus microbiota in men that remained uncircumcised showed minor variations from enrollment (in blue) to year-1 (in orange) ([Fig. 2A](#fig2){ref-type="fig"}). In contrast, significant shifts were seen in the circumcised men ([Fig. 2B](#fig2){ref-type="fig"}).](mbo0021314930002){#fig2}

Circumcision significantly reduced previously abundant coronal sulcus bacteria. {#h1.8}
-------------------------------------------------------------------------------

To quantify the impact of MC on coronal sulcus bacteria, we determined the MC effect size. This was performed for genera that either significantly decreased (i.e., "negative responders") or increased (i.e., "positive responders") after MC ([Table 4](#tab4){ref-type="table"}). Among the negative responders, *Prevotella* spp., *Porphyromonas* spp., *Finegoldia* spp., and *Peptostreptococcus* spp. decreased in both prevalence and absolute abundance, with effective load reductions ranging from −1,157 to −25,327 16S rRNA gene copies ([Table 4](#tab4){ref-type="table"}). Other negative responders decreased significantly in either prevalence (*n* = 8) or absolute abundance (*n* = 2). Several negative responders had substantial effective load reductions that were also highly variable, such as unclassified *Clostridiales*, *Peptoniphilus* spp., and *Murdochiella* spp. As a result, they have large but non-statistically significant effect sizes ([Table 4](#tab4){ref-type="table"}).

###### 

Effect size of MC, measured as the change in absolute abundances of coronal sulcus bacteria that significantly decreased (i.e., "negative responders") or increased (i.e., "positive responders") post-MC, adjusted by changes in abundance among uncircumcised men over time^[*a*](#ngtab4.1)^

  Category and bacterial group^[*b*](#ngtab4.2)^   Indicator value (FDR-adjusted *P* value)   MC effect size \[mean (90% CI)\]
  ------------------------------------------------ ------------------------------------------ ----------------------------------
  Negative responders to MC                                                                   
   *Prevotella* spp.\*\*\*                         0.18 (0.06)                                −25,327 (−48,812 to −3,988)
   *Porphyromonas* spp.\*\*\*                      0.27 (\<0.01)                              −14,232 (−28,698 to −2,358)
   Unclassified *Clostridiales* spp.\*             0.24 (0.01)                                −10,087 (−32,278 to 12,802)
   Unclassified *Clostridiales* family XI\*        0.22 (0.03)                                −3,299 (−8,715 to 647)
   *Murdochiella* spp.\*                           0.30 (\<0.01)                              −3,207 (−10,314 to 5,319)
   *Peptoniphilus* spp.\*                          0.29 (\<0.01)                              −1,349 (−8,121 to 5,388)
   *Finegoldia* spp.\*\*\*                         0.24 (0.07)                                −1,343 (−2,385 to −438)
   *Anaerococcus* spp*.*\*\*                       0.27 (0.03)                                −1,284 (−2,292 to −337)
   *Peptostreptococcus* spp*.*\*\*\*               0.21 (\<0.01)                              −1,157 (−2,415 to −188)
   *Mobiluncus* spp*.*\*                           0.16 (0.02)                                −568 (−1,480 to 290)
   *Actinomyces* spp.                              0.20 (0.01)                                −286 (−780 to 13)
   *Saccharofermentans* spp.                       0.16 (0.03)                                −281 (−1,545 to 1,032)
   *Negativicoccus* spp*.*\*                       0.28 (\<0.01)                              −244 (−785 to 321)
   *Sutterella* spp*.*\*                           0.13 (0.01)                                −110 (−258 to 12)
   *Howardella* spp.                               0.14 (0.01)                                −44 (−175 to 75)
   *Olsenella* spp*.*\*                            0.17 (0.01)                                −37 (−270 to 171)
   *Ralstonia* spp.                                0.14 (0.01)                                0 (0 to 1)
   *Dialister* spp*.*\*                            0.24 (\<0.01)                              1,434 (−1,259 to 4,618)
  Positive responders to MC                                                                   
   *Rothia* spp.                                   0.12 (\<0.01)                              1 (0 to 2)
   *Roseomonas* spp.                               0.11 (0.04)                                1 (0 to 2)
   *Kocuria* spp*.*\*\*\*                          0.32 (\<0.01)                              8 (5 to 11)
   *Brevibacterium*\*\*\*                          0.30 (\<0.01)                              13 (5 to 22)
   *Eremococcus*\*\*                               0.26 (0.06)                                45 (8 to 94)
   *Bifidobacterium*                               0.16 (\<0.01)                              101 (−7 to 243)
   *Helcococcus*\*\*\*                             0.21 (0.02)                                161 (22 to 345)
   *Staphylococcus*\*\*\*                          0.56 (\<0.01)                              259 (168 to 353)
   *Corynebacterium*\*\*\*                         0.50 (\<0.01)                              2,857 (1,440 to 4,722)

 The negative and positive responders to MC were identified using indicator analysis, which also produced the indicator values.

 \*, significant change in prevalence only; \*\*, significant change in absolute abundance (i.e., load) only; \*\*\*, significant change in both prevalence and absolute abundance.

In contrast, many positive responders had smaller MC effect sizes that were statistically significant, a finding that indicated a more uniform bacterial gain among circumcised men. On average, Coryneb*acterium* spp. increased by 2,860 and *Staphylococcus* spp. by 249 16S rRNA gene copies per individual ([Table 4](#tab4){ref-type="table"}). The third-highest mean MC effect size was seen in *Helcococcus* spp., which belong to *Clostridiales* family XI, and that response contrasts with the broadly negative impact of MC on other *Clostridiales* family XI members. Overall, the relatively larger MC effect sizes in negative responders indicate that MC primarily reduced previously abundant coronal sulcus bacteria, accompanied by other minor abundance gains.

DISCUSSION {#h2}
==========

In a randomized trial of MC, we showed that MC significantly reduced the bacterial load by reducing both the prevalence and the absolute abundance of many coronal sulcus bacteria. The two study groups had comparable coronal sulcus microbiota at enrollment that consisted of multiple microbiota types, but MC profoundly altered the composition of the microbiota and reduced its biodiversity. Over time, changes in the coronal sulcus microbiota were observed in the uncircumcised men. However, after adjusting for these temporal changes, we found that there were significantly greater decreases in the total bacterial load, microbiota biodiversity, and microbiota composition in the circumcised men that were attributable to MC.

The role of coronal sulcus bacteria in heterosexual HIV acquisition remains unknown. Recent studies suggest that the non-STI genital bacteria may affect the susceptibility of foreskin HIV target cells ([@B22], [@B24]). Of the HIV target cell types found in the foreskin, Langerhans cells (LCs) have been hypothesized to play a key role in mediating HIV infection ([@B24]). Located proximal to the epithelial surface, naive LCs bind, internalize, and degrade HIV particles; however, when activated by a high HIV load, active STIs, or bacterium-associated inflammatory mediators, such as lipopolysaccharide (LPS) and tumor necrosis factor alpha (TNF-α), LCs bind and present HIV particles to CD4^+^ T cells ([@B24], [@B25]).

As already mentioned, the changes in penile microbiota and STI incidence after MC may be attributable not only to the anatomic alteration itself but also to behavioral changes in circumcised men or men enrolled in a clinical trial in general. However, analysis of the Rakai data showed that MC did not significantly alter behavior during the trial ([@B1]). Likewise, the natural dynamics of the circumcised coronal sulcus microbiota are unknown, but sampling performed 1 year postcircumcision likely represents a persistent change. Our use of novel analysis metrics, such as the log response ratio and MC effect size, permitted adjustment for the impact of time and trial participation, which allowed us to quantify microbiota changes attributable solely to MC.

MC has been associated with reduction of bacterial vaginosis (BV) in female sexual partners, but the sharing of genital microbiota between sexual partners is not well understood ([@B6], [@B26]). We found that a subset of bacteria associated with BV decreased after MC, including *Prevotella* spp., *Fusobacterium* spp., and *Mobiluncus* spp., while others, such as *Gardnerella* spp., *Sneathia* spp., *Actinomyces* spp., *Atopobium* spp., *Megasphaera* spp., and *Veillonella* spp., were not significantly altered.

MC selected for bacteria capable of surviving in the aerated circumcised microenvironment. At enrollment, the microbiota types were comparable in the two study groups. However, nearly all of the bacteria that decreased after MC were strict anaerobes, except for *Actinomyces* spp. and *Arcanobacterium* spp., which are facultative anaerobes. We also show that as a facultative anaerobe ([@B27]), *Helcococcus* spp. constituted the single positive responder to MC in *Clostridiales* family XI. The large competitive advantage of a single genus from a previously diverse and abundant bacterial family illustrates the strong and functionally cohesive selective pressure exerted by MC through changes to the coronal sulcus microenvironment.

One of the largest positive responders to MC was the *Staphylococcus* species group. Although we did not attempt to perform species-level analysis, the most abundant *Staphylococcus* bacteria on the post-MC coronal sulcus included *S. haemolyticus*, *S. hominis*, *S. epidermidis*, *S. xylosus*, and their genetic near neighbors. It is important to note that *S. aureus* and *S. epidermidis* are common commensals on exposed human epithelial and mucosal surfaces. Thus, their increase post-MC is unlikely to affect the pathogenic potential.

We integrated culture-independent bacterial identification, an ecological analytical framework, and a randomized study design to reveal the impact of MC on the penis microbiome. Combining bacterial quantification with parallel sequencing showed that circumcision resulted in significant decreases in the absolute abundances of several anaerobic bacterial taxa that defined the uncircumcised penis microbiome. Currently, we know little about the role of these fastidious anaerobes in the male urogenital tract or the broader context of human health. Future studies are required to determine if a decreased anaerobic bacterial load modifies foreskin inflammation and HIV target cell recruitment/susceptibility, which may play a role in HIV risk reduction conferred by MC.

MATERIALS AND METHODS {#h3}
=====================

Study design and subjects. {#h3.1}
--------------------------

We conducted a randomized trial of MC for HIV prevention in 2004 to 2006 ([@B1]). In this study, HIV-negative, uncircumcised men of ages 15 to 49 were randomized to either immediate circumcision (intervention group) or circumcision delayed for 24 months (control group), as described previously ([@B1], [@B4]). All circumcision procedures were performed in one surgical facility by the same team of urologists and trained medical officers, using a single surgical procedure, the "sleeve method" of circumcision. Prophylactic antibiotics were not used for these procedures, and antibiotic use in this geographic region was minimal. Study participants were provided access to regular reproductive health services and followed at 6, 12, and 24 months to assess HIV and sexually transmitted infection (STI) acquisition, as described in detail elsewhere ([@B1]). Men with a diagnosis of syphilis or symptoms suggestive of an STI were treated, but this was uncommon. Specifically, there were three new cases of syphilis in the control group and one new case in the intervention group who were treated with intramuscular benzathine penicillin. In addition, five control group men but none from the intervention group were treated for STI symptoms at month 6, and three control group men and three intervention group men were treated at year 1. Symptomatic patients were given azithromycin, ciprofloxacin, or metronidazole. HSV-2 and HPV data were not available at the time of the trial, and thus no treatment was given.

At each visit, clinicians collected penile swabs from the coronal sulcus as follows. Sterile cotton-tipped applicators (Thermo, Fisher Scientific, Waltham, MA) were premoistened with sterile saline and rolled over the coronal sulcus twice in a nontraumatic fashion. The swabs were immediately placed in 1 ml of Amplicor specimen transport medium (Roche Diagnostics, Indianapolis, IN) and stored at −80°C until analysis. In this analysis, we evaluated the enrollment and year 1 swabs from 77 control and 79 intervention arm participants, selected at random from among all married men who, together with their spouses, remained persistently HIV negative during the trial. The study was approved by four institutional review boards: the Science and Ethics Committee of the Uganda Virus Research Institute (Entebbe, Uganda), the HIV subcommittee of the National Council for Science and Technology (Kampala, Uganda), the Committee for Human Research at Johns Hopkins University's Bloomberg School of Public Health (Baltimore, MD), and the Western Institutional Review Board (Olympia, WA).

Sample processing. {#h3.2}
------------------

We processed samples from each participant in the same batch to control for interrun variation. For each sample, we lysed 100 µl of eluted transport medium using enzyme-free chemical and mechanical lysis. We purified the lysate using a Qiagen AllPrep DNA/RNA minikit (Qiagen, Valencia, CA) and performed DNA elution using 100 µl of buffer EB. Additional methodological details can be found in [Text S1](#supplS1){ref-type="supplementary-material"} in the supplemental material.

Bacterial load quantification and 16S rRNA gene-based pyrosequencing analysis. {#h3.3}
------------------------------------------------------------------------------

We quantified the bacterial load, measured as the bacterial 16S rRNA gene copies per μl of coronal sulcus swab eluent, using a broad-coverage qPCR assay ([@B28]). We also generated bar-coded V3-V6 amplicons using broad-coverage fusion PCR primers, which were pooled and sequenced on the Genome Sequencer FLX instrument (Roche Applied Science, Branford, CT). Resultant pyrosequences were chimera checked ([@B29]), demultiplexed, and quality checked ([@B30]). We performed taxonomic classification using the Ribosomal Database Project Naïve Bayesian Classifier (RDP release 10, update 28) ([@B31]). Detailed description of the bioinformatics analyses can be found in [Text S1](#supplS1){ref-type="supplementary-material"} in the supplemental material.

After stringent filtering, pyrosequencing yielded a total of 104,425 16S rRNA gene sequences for samples from control men at enrollment and 90,560 at year 1; for the intervention group, there were 88,834 16S rRNA gene sequences at enrollment and 66,265 at year 1. These sequences represented 18 phyla, 31 classes, 49 orders, 121 families, and 306 genera at a ≥80% bootstrap confidence level after excluding taxonomic groups with only a single sequence detected from the full sample set. For *Clostridiales* and *Clostridiales* family XI, many sequences could not be further classified at a ≥80% bootstrap confidence level. These were included in the data set as unclassified *Clostridiales* and unclassified *Clostridiales* family XI, respectively.

Bacterial load comparison. {#h3.4}
--------------------------

We expressed the bacterial load change in each participant over time as a log response ratio (LRR) using the following: ln\[(bacterial load at year 1)/(bacterial load at baseline)\] ([@B32]). LRR quartiles and means for participants from each group were plotted in the R (version 2.13.1) software environment ([@B33]) and compared used a two-tailed *t* test with unequal variance at an α value of 0.05.

16S rRNA gene-based microbiota comparative analysis. {#h3.5}
----------------------------------------------------

We analyzed the coronal sulcus microbiota based on operational taxonomic unit (OTU), i.e., the unique bacterial groups detected at each taxonomic level. We converted the per-participant OTU data into four metrics: prevalence, relative abundance, absolute abundance, and log-transformed absolute abundance.

We calculated each OTU's prevalence as (total number of participants positive for the OTU in group X)/(total number of participants in group X) and the relative abundance as (number of sequences assigned to the OTU in participant A)/(total number of sequences from participant A). We calculated absolute abundance using the formula (relative abundance of each OTU in participant A) *×* (bacterial load in participant A) and the log-transformed absolute abundance as ln(absolute abundance *+* 1).

For the 40 most common genera at enrollment, we compared the baseline prevalences and relative abundances between the study arms using the chi-square test and two-tailed *t* test, respectively. We assessed the change in prevalence (i.e., ΔPrevalence) at year 1 in each arm using a presence-absence data matrix and a two-tailed paired *t* test. All *P* values were adjusted for false discovery. The ΔPrevalences between the circumcised and uncircumcised men were further compared based on the following: ΔΔPrevalence = \[(ΔPrevalence~intervention~) − (ΔPrevalence~control~)\].

We compared the change in overall microbiota composition visually based on family-level log-transformed absolute abundance data using nonmetric multidimensional scaling (nMDS) and Bray-Curtis distance ([@B34]--[@B36]). The resultant nMDS plots were annotated with centroids and 95% confidence ellipses ([@B34]). We assessed the microbiota change over time for each study group using permutational multivariate analysis of variance (PerMANOVA) ([@B34]) based on the log-transformed absolute abundance data in Euclidean distance.

We assessed the change in microbiota biodiversity in each group using two biodiversity metrics: diversity (*D*), calculated as *D* = Simpson's diversity index, and evenness (*E*), calculated as *E* = *D*/*S*, where *S* is richness ([@B37]). Evenness reflects the dominance by many (i.e., high evenness) versus few (i.e., low evenness) OTUs, whereas richness is a measurement of the total number of unique OTUs present. We calculated Δ*E* and Δ*D* for each individual and applied bootstrapping to generate random control-intervention pairs (*i* = 1,000). We estimated the mean *E* and *D* effect sizes (ES) as follows: mean *E*~ES~ = mean (Δ*E*~intervention\ *Xi*~ − Δ*E*~control\ *Yi*~) and mean *D*~ES~ = mean (Δ*D*~intervention\ *Xi*~ − Δ*D*~control\ *Yi*~), as well as the accompanying 95% confidence intervals.

We identified indicator bacterial genera impacted significantly by MC with indicator species analysis using log-transformed data ([@B38]). For these indicator genera, we quantified the mean MC effect sizes and the 90% confidence intervals. Detailed description of the statistical analyses can be found in [Text S1](#supplS1){ref-type="supplementary-material"} in the supplemental material.

Literature review. {#h3.6}
------------------

We performed a literature review of the oxygen tolerance of the 40 most common genera in the uncircumcised-group microbiota. Bergey's Manual of Determinative Bacteriology ([@B39]) was used for *Corynebacterium* spp., *Lactobacillus* spp., *Staphylococcus* spp., and *Streptococcus* spp. For others, we performed a search of the MEDLINE database via the PubMed tool with a cutoff date of April 2012 using a combined term of the applicable genus name and "*nov*" to identify publications defining new species within the genus. Detailed results from the literature review can be found in [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material.

SUPPLEMENTAL MATERIAL {#h4}
=====================

###### 

Detailed laboratory protocols and bioinformatic methods. Download

###### 

Text S1, DOC file, 0.1 MB

###### 

An nMDS plot comparing changes in the coronal sulcus microbiota composition from enrollment (in orange) to year 1 (in blue) in the two study groups (see key, top left). Each data point represents an individual's microbiota at a given time point. The centroids and 95% confidence ellipses for each group are as shown. The microbiota composition at enrollment was similar between the controls and the intervention groups and remained largely unchanged among the uncircumcised men at year 1. In contrast, microbiota composition for the circumcised men changed significantly post-MC and formed a cluster distinct from the uncircumcised-group microbiota profiles. Download

###### 

Figure S1, PDF file, 1.1 MB

###### 

Comparison of year-1 prevalence, as well as changes in prevalence from enrollment to year 1 for uncircumcised versus circumcised men for all detected coronal sulcus bacterial genera.

###### 

Table S1, DOCX file, 0.2 MB.

###### 

References for oxygen tolerance designations.

###### 

Table S2, DOCX file, 0.1 MB.
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